Incidence of tuberculosis in injection drug users in San Francisco impact of anergy

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 1, 1998, Pages 19-22

  Daley, Charles L ^a   Hahn, Judith A ^b   Moss, Andrew R ^b   Hopewell, Philip C ^b   Schecter, Gisela F ^b  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; METHADONE;

ARTICLE; CLONAL ANERGY; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031893791     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.1.9701111     Document Type: Article

References (13)

1. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550.
2. Guelar, A., J. M. Gatell, J. Verdejo, D. Podzamczer, L. Lozano, E. Aznar, J. M. Miro, J. Mallolas, L. Zamora, J. Gonzalez, and E. Soriano. 1993. A prospective study of the risk of tuberculosis among HIV-infected patients. A.I.D.S. 7:1345-1349.
3. Graham, N. M. H., K. E. Nelson, L. Solomon, M. Bonds, R. T. Rizzo, J. Scavotto, J. Astemborski, and D. Vlahov. 1992. Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and seronegative intravenous drug users. J.A.M.A. 267:369-373.
4. Markowitz, N., N. I. Hansen, T. C. Wilcosky, P. C. Hopewell, J. Glassroth, P. A. Kvale, B. T. Mangura, D. Osmond, J. M. Wallace, M. J. Rosen, and the Pulmonary Complications of HIV Infection Study Group. 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann. Intern. Med. 119:185-193.
5. Selwyn, P. A., B. M. Sckell, P. Alcabes, G. H. Friedland, R. S. Klein, and E. E. Schoenbaum. 1992. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. J.A.M.A. 268:504-509.
6. Moreno, S., J. Baraia-Etxaburu, E. Bouza, F. Parras, M. Pétrez-Tascón, P. Miralles, T. Vicente, J. C. Alberdi, J. Cosín, and D. López-Gay. 1993. Risk for developing tuberculosis among anergic patients infected with HIV. Ann. Intern. Med. 119:194-198.
7. Centers for Disease Control. 1991. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk for tuberculosis. Morbid. Mortal. Weekly Rep. 40(Suppl. RR-5):27-33.
8. Centers for Disease Control and Prevention. 1990. Case definitions for public health surveillance. Morbid. Mortal. Weekly Rep. 39(RR-13): 1-13.
9. Small, P. M., P. C. Hopewell, S. P. Singh, A. P. Paz, J. Parsonnet, D. C. Ruston, G. F. Schecter, C. L. Daley, and G. K. Schoolnik. 1994. The epidemiology of tuberculosis in San Francisco. N. Engl. J. Med. 330: 1703-1708.
10. Daley, C. L., P. M. Small, G. F. Schecter, G. K. Schoolnik, R. A. McAdam, W. R. Jacobs, and P. C. Hopewell. 1992. Transmission and accelerated progression of tuberculosis in patients infected with the human immunodeficiency virus: chacterization of an outbreak using restriction fragment length polymorphism analysis. N. Engl. J. Med. 326:321-325.
11. MacGregor, R. R., D. Dunbar, and A. L. Graziani. 1994. Tuberculin reactions among attendees at a methadone clinic: relation to infection with the human immunodeficiency virus. Clin. Infect. Dis. 19:1100-1104.
12. Graham, M. N. H., N. Galai, K. E. Nelson, J. Astemborski, M. Bonds, R. T. Rizzo, L. Sheeley, and D. Vlahov. 1996. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch. Intern. Med. 156:889-894.
13. Chin, D. P., D. Osmond, K. Page-Shafer, J. Glassroth, M. J. Rosen, L. B. Reichman, P. A. Kvale, J. M. Wallace, W. K. Poole, P. C. Hopewell, and the Pulmonary Complications of HIV Infection Study Group. 1996. Reliability of anergy skin testing in persons with HIV infection. Am. J. Respir. Crit. Care Med. 153:1982-1984.